However, unlike pediatric COVID-19, individuals with MIS-C had reduced numbers of T cells as compared with pediatric controls, with 1.6-fold fewer CD4+ T cells (95% CI: 2.04–1.26; p = 3.28 × 10–4) and 1.42-fold fewer CD8+ T cells (95% CI: 1.87–1.07; p = 0.016) (Figure 4A and Table 5). This evidence concerns the gene CD8A and COVID-19.